0000899243-18-006041.txt : 20180302
0000899243-18-006041.hdr.sgml : 20180302
20180302141403
ACCESSION NUMBER: 0000899243-18-006041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180301
FILED AS OF DATE: 20180302
DATE AS OF CHANGE: 20180302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sprague John M
CENTRAL INDEX KEY: 0001730056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36571
FILM NUMBER: 18661180
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: T2 Biosystems, Inc.
CENTRAL INDEX KEY: 0001492674
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 204827488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-457-1200
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-01
0
0001492674
T2 Biosystems, Inc.
TTOO
0001730056
Sprague John M
101 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
5.08
2018-03-01
4
A
0
225000
0.00
A
2028-03-01
Common Stock
225000
225000
D
25% of the total shares vest on 01/30/2019, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 01/30/2022.
/s/ Michael Gibbs, Attorney-in-fact
2018-03-02